Subclinical hypothyroidism

Area of Science:

• Endocrinology
• Thyroid Disorders
• Internal Medicine

Background:

• Subclinical hypothyroidism (SCH) is characterized by elevated thyroid-stimulating hormone (TSH) levels with normal free thyroxine (T4) and triiodothyronine (T3).
• Its prevalence varies globally, influenced by factors such as age, sex, and iodine intake.
• Understanding SCH is crucial due to its potential to progress to overt hypothyroidism and associated cardiovascular risks.

Purpose of the Study:

• To provide a comprehensive overview of subclinical hypothyroidism.
• To elucidate the underlying causes and epidemiological characteristics of SCH.
• To discuss the natural history, clinical manifestations, and therapeutic interventions for SCH.

Main Methods:

• This overview synthesizes existing literature on subclinical hypothyroidism.
• It includes a review of etiological factors, diagnostic criteria, and prevalence data.
• The discussion encompasses progression rates, clinical findings, and current treatment guidelines.

Main Results:

• Subclinical hypothyroidism has diverse etiologies, including autoimmune thyroiditis and iodine deficiency.
• Prevalence is significant, particularly in certain demographic groups.
• A subset of individuals with SCH will progress to overt hypothyroidism, with varying rates depending on TSH levels and other risk factors.
• Clinical abnormalities may be subtle or absent in many cases.

Conclusions:

• Subclinical hypothyroidism represents a spectrum of thyroid dysfunction requiring careful evaluation.
• Monitoring and timely intervention are essential for managing patients at risk of progression.
• Treatment decisions should be individualized based on TSH levels, presence of thyroid antibodies, and patient symptoms.